Learn how to utilize the features of your instrumentation to enhance your workflow. Discover ways to reduce your sample prep time. Learn how one system meets the needs of both R&D and QA/QC ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

This webinar will introduce you to some considerations and solutions for integration of chromatogram and processing of data using Agilent OpenLAB Chemstation. Topics include useful knowledge for ...

Bay Area laboratory solutions company Agilent Technologies has agreed to acquire Biocare Medical, a pathology solutions business, in an all-cash transaction valued at $950 million. Agilent aims to ...

Citi is positioning selectively across life sciences by favoring recovery names with clear catalysts while avoiding companies navigating accounting uncertainty, with Agilent’s pending Biocare deal ...

Agilent Technologies acquires Biocare Medical for $950M to expand into high-growth pathology and cancer diagnostics, enhancing recurring consumables revenue streams. Agilent trades below historical ...

Agilent Technologies Inc. agreed to acquire privately held Biocare Medical, which makes instruments and materials used in cancer research, in an all-cash transaction valued at $950 million. Biocare ...

Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be ...

Healing from trauma is often depicted in popular culture as a heroic battle with painful memories. Often, we see a solitary individual confronting their darkest moments and emerging changed. Yet, real ...

Mayor-elect Zohran Mamdani has spoken about integrating America’s largest education system in striking terms rarely heard from big city leaders. By Troy Closson More than 71 years ago, the United ...

Agilent Technologies President and CEO Padraig McDonnell joins 'Mad Money' host Jim Cramer to talk quarterly results, where it is seeing growth opportunities, the type of research it is supporting and ...